Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Apr 18, 2019 3:26pm

97 Views

Post# 29646417

RE:RE:15/492,801 - Status: Notice of Allowance Mailed

This will be a great NR

boiler room gonna let it fly for frusty
10 months left scumbags,,, better let it run to dolla and make some money on your .54's

Gustoes wrote: We have a patent boys and girls!?

Report abuse on the FOD crew.

Stockhouse should be embarrassed and refund their advertisers for letting these scum run the bullboards.

Gustoes wrote:
Claim modifications:

https://www.scribd.com/document/406739826/15492801-0

https://www.scribd.com/document/406739827/15492801-1

https://www.scribd.com/document/406739828/15492801-2

https://www.scribd.com/document/406739829/15492801-3

https://www.scribd.com/document/406739830/15492801-4

https://www.scribd.com/document/406739832/15492801-5

https://www.scribd.com/document/406739831/15492801-6

Done.

Status: Notice of Allowance Mailed -- Application Received in Office of Publications

What is a Notice of Allowance?

A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office (USPTO) after a patent examiner has decided to issue the requested patent. The Notice of Allowance comes after the inventor has turned in a patent application and provided all information about the invention. This information includes the patent's description, design, drawings, or blueprints.

Since the Notice of Allowance shows the application is complete and meets all requirements, it is the final step in the long and complex patent application process. Your patent application has been fully reviewed and your invention has been given the green light for patenting. All that's left is to pay remaining fees and send any drawing corrections.

Fees due: $500.00 May 21st, 2019